Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

View:
Post by DavidKingCanada on Oct 22, 2021 10:00am

Few Points

The two people running this Company are still in charge even though one was suppose to Retire.

We have a few more faces on board, some very highly qualified individuals. I am excited.

60:1 leaves us with 7 Million Shares plus whatever Warrants.
There is no one this Forum who can do anything about that. Retiredcop told us to send Management an email, not going to work. 

Boston Group is looking for a quick takeover and then a possible Buyout.

Future looks bright and always keep in mind we have Invested in a highly volatile Penny Stock that is soon to be listed on the Nasdaq if all goes well!

I say it's time to sit back and Celebrate!

Comment by Thenorth1990 on Oct 22, 2021 3:21pm
So sending the email is not to reverse any decisions , but a plea to get information out which a lot of us feel is withheld in regards to serology test and it's progress. And they have provided us with some insight in the past. How Data helps investors for eg. If an investor in promis says its a long term game but then end up with an assumption that boston bought in at us 19 cents and sold for ...more  
Comment by DavidKingCanada on Oct 22, 2021 3:43pm
Thenorth, there was no mention of a Serology Test and there probably won't be until everything else is put in place. Imo, dropping the Serology Test would be beneficial to the Company. Covid is Over! There are TONS of other Companies leaps and bounds ahead of PMN in regards to any sort of Serology Tests. Sorry to break it to you all. 
Comment by Thenorth1990 on Oct 22, 2021 3:53pm
Agree that there are tons of companies out there already doing it .. Disagree on the rest. Canada is making covid passport mandatory for flying . May be covid is over for the stock market but not for people with senior parents /grandparents. I am dillusional to think this is gonna bring $50mn revenue , it's all about investor confidence. I think they are saving the news until Nasdaq debut, buy ...more  
Comment by DavidKingCanada on Oct 22, 2021 4:39pm
Thenorth, agree with suppressing information. They should really give us some sort of pr.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities